B-cell Malignancies: Clinical Trials

2 trials for B-cell Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Recruiting 1, Unknown 1

Follow B-cell Malignancies: new trials by email Literature Review of B-cell Malignancies trials Research Report on B-cell Malignancies

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies
in vivo CAR-T drug based on LNP-mRNA - B-cell Malignancies
Early Phase 1RecruitingXinqiao Hospital of Chongqing472025-12-202026-01-20
Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies
Low dose ET019002- T Cells, Middle dose ET019002- T Cells, High dose ET019002- T Cells - B-Cell Malignancies
Early Phase 1UnknownFirst Affiliated Hospital Xi'an Jiaotong University182018-08-192018-08-23

Sponsors

First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Xinqiao Hospital of Chongqing (1)

Countries

China (1)

Results publications

PMID 35776199